Trimas Corp
TRS Nasdaq Metal Forgings & Stampings Financials FY2016βFY2025
What Trimas Corp does
No business description yet.
- Legal name
- TRIMAS CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 2, 2026
- Accession Β· CIK
- 0000842633-26-000012
0000842633
Revenue and margins
Trimas Corp had $646M of revenue in fiscal 2025, up 2.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $69.1M in fiscal 2025, 10.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Trimas Corp returned $110M to shareholders in fiscal 2025, 159% of free cash flow. The diluted share count rose 0.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Trimas Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $141M | $112M | $34.9M | $23.1M | $30.0M |
| Debt incl. finance leases | $400M | $400M | $402M | $403M | $474M |
| Net debt / EBITDA | 1.7x | 1.9x | 3.4x | 4.7x | 5.5x |
| Debt / equity | 0.6x | 0.6x | 0.6x | 0.6x | 0.7x |
| Interest coverage | 6.6x | 7.0x | 3.2x | 0.8x | 2.3x |
| Current ratio | 2.8x | 3.0x | 2.5x | 2.7x | 2.5x |
| Quick ratio | 1.8x | 1.9x | 1.3x | 2.0x | 1.9x |
| Total assets | $1.3B | $1.3B | $1.3B | $1.3B | $1.5B |
| Total liabilities | $673M | $653M | $659M | $657M | $779M |
| Shareholders' equity | $631M | $652M | $683M | $667M | $706M |
| Net debt (β = net cash) | $259M | $288M | $367M | $380M | $444M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 7 / 9 | 7 / 9 | 6 / 9 | 4 / 9 | 8 / 9 | 8 / 9 | 5 / 9 | 5 / 9 | 4 / 9 |
| Accruals ratio | β11.4% | β8.5% | β4.3% | 2.0% | β17.4% | β6.2% | β0.5% | β3.6% | β3.0% | 0.2% |
| Altman Z'' | 0.87 | 2.14 | 3.10 | 3.50 | 1.25 | 2.61 | 2.89 | 2.52 | 2.52 | 2.65 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $794M | $656M | $705M | $724M | $770M | $857M | $884M | $652M | $631M | $646M |
| Gross profit | $211M | $189M | $200M | $194M | $182M | $217M | $208M | $153M | $130M | $138M |
| Operating income | β$41.9M | $92.7M | $109M | $91.2M | β$88.3M | $95.1M | $99.1M | $50.7M | $15.2M | $41.3M |
| Interest expense | $13.7M | $14.4M | $13.9M | $14.0M | $14.7M | $14.5M | $14.1M | $15.9M | $19.6M | $18.0M |
| Pretax income | β$58.2M | $69.9M | $92.4M | $78.3M | β$103M | $69.1M | $87.7M | $35.9M | β$4.2M | $24.3M |
| Income tax | β$18.4M | $33.9M | $18.7M | $16.3M | β$23.0M | $11.8M | $21.5M | $6.3M | β$2.2M | β$48.1M |
| Net income | β$39.8M | $31.0M | $83.3M | $98.6M | β$79.8M | $57.3M | $66.2M | $40.4M | $24.3M | $120M |
| Diluted EPS | β$0.88 | $0.67 | $1.80 | $2.16 | β$1.83 | $1.32 | $1.56 | $0.97 | $0.60 | $2.95 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $80.5M | $120M | $129M | $75.6M | $127M | $134M | $72.6M | $88.2M | $63.8M | $117M |
| Capital expenditure | $31.3M | $33.7M | $23.4M | $29.7M | $40.5M | $45.1M | $46.0M | $54.2M | $51.0M | $48.4M |
| Free cash flow | $49.1M | $86.4M | $106M | $45.9M | $86.9M | $89.2M | $26.6M | $34.0M | $12.8M | $69.1M |
| Depreciation and amortization | $44.9M | $40.3M | $40.5M | $43.5M | $49.8M | $53.5M | $53.2M | $57.6M | $64.9M | $39.7M |
| Stock-based compensation | $6.9M | $6.8M | $7.2M | $6.5M | $8.2M | $9.5M | $9.8M | $9.7M | $7.0M | $11.5M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $67.1M | $194M | $34.3M | $64.1M | $77.3M | $0.0M | $37.7M |
| Share buybacks | $0.0M | $0.0M | $12.1M | $36.7M | $39.4M | $19.1M | $36.9M | $18.8M | $19.3M | $103M |
| Dividends paid | β | β | β | $0.0M | $0.0M | $1.7M | $6.9M | $6.7M | $6.6M | $6.6M |
| Dividends and buybacks | $0.0M | $0.0M | $12.1M | $36.7M | $39.4M | $20.8M | $43.8M | $25.5M | $25.9M | $110M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $20.7M | $27.6M | $108M | $172M | $74.0M | $141M | $112M | $34.9M | $23.1M | $30.0M |
| Total debt | $393M | $311M | $300M | $300M | $350M | $400M | $400M | $400M | $402M | $473M |
| Finance lease liabilities | β | β | β | β | β | β | β | $2.2M | $1.6M | $1.4M |
| Current assets | $309M | $311M | $412M | $434M | $352M | $432M | $423M | $397M | $427M | $463M |
| Current liabilities | $133M | $122M | $142M | $120M | $137M | $155M | $140M | $159M | $159M | $184M |
| Inventory | $160M | $155M | $127M | $133M | $149M | $152M | $163M | $192M | $110M | $109M |
| Property and equipment, net | $179M | $190M | $172M | $214M | $253M | $266M | $278M | $330M | $238M | $248M |
| Goodwill | $315M | $319M | $317M | $335M | $304M | $315M | $340M | $294M | $287M | $300M |
| Intangible assets | $214M | $194M | $168M | $161M | $206M | $197M | $188M | $181M | $78.4M | $76.6M |
| Total assets | $1.1B | $1.0B | $1.1B | $1.2B | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B | $1.5B |
| Total liabilities | $552M | $489M | $480M | $495M | $610M | $673M | $653M | $659M | $657M | $779M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $500M | $544M | $620M | $697M | $584M | $631M | $652M | $683M | $667M | $706M |
| Margins | ||||||||||
| Gross margin | 26.5% | 28.8% | 28.4% | 26.8% | 23.6% | 25.3% | 23.6% | 23.5% | 20.5% | 21.4% |
| Operating margin | β5.3% | 14.1% | 15.4% | 12.6% | β11.5% | 11.1% | 11.2% | 7.8% | 2.4% | 6.4% |
| EBITDA margin | 0.4% | 20.3% | 21.2% | 18.6% | β5.0% | 17.3% | 17.2% | 16.6% | 12.7% | 12.5% |
| Net margin | β5.0% | 4.7% | 11.8% | 13.6% | β10.4% | 6.7% | 7.5% | 6.2% | 3.8% | 18.6% |
| FCF margin | 6.2% | 13.2% | 15.0% | 6.3% | 11.3% | 10.4% | 3.0% | 5.2% | 2.0% | 10.7% |
| Returns | ||||||||||
| Return on capital | β3.8% | 7.3% | 10.7% | 8.8% | β8.1% | 8.9% | 8.0% | 4.0% | 1.1% | 3.6% |
| Return on capital employed | β4.6% | 10.2% | 11.3% | 8.5% | β8.4% | 8.3% | 8.5% | 4.3% | 1.3% | 3.2% |
| Return on equity | β8.0% | 5.9% | 14.3% | 15.0% | β12.4% | 9.4% | 10.3% | 6.0% | 3.6% | 17.5% |
| Return on assets | β3.8% | 3.0% | 7.8% | 8.6% | β6.7% | 4.6% | 5.1% | 3.0% | 1.8% | 8.6% |
| Return on tangible equity | β | 101.8% | 61.3% | 49.0% | β107.7% | 48.3% | 53.4% | 19.4% | 8.0% | 36.5% |
| Growth | ||||||||||
| Revenue growth | β | β17.4% | 7.4% | 2.6% | 6.4% | 11.3% | 3.1% | β26.2% | β3.3% | 2.4% |
| Net income growth | β | β | 169.1% | 18.4% | β180.9% | β | 15.5% | β39.0% | β39.9% | 395.4% |
| EPS growth | β | β | 168.7% | 20.0% | β184.7% | β | 18.2% | β37.8% | β38.1% | 391.7% |
| FCF growth | β | 75.7% | 22.6% | β56.6% | 89.3% | 2.6% | β70.2% | 27.7% | β62.3% | 439.0% |
| Share count change | β | 1.3% | 0.4% | β1.2% | β4.4% | β0.7% | β1.9% | β1.9% | β2.3% | 0.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 127.1x | 2.1x | 1.3x | 0.9x | β | 1.7x | 1.9x | 3.4x | 4.7x | 5.5x |
| Debt / equity | 0.8x | 0.6x | 0.5x | 0.4x | 0.6x | 0.6x | 0.6x | 0.6x | 0.6x | 0.7x |
| Interest coverage | β3.1x | 6.4x | 7.8x | 6.5x | β6.0x | 6.6x | 7.0x | 3.2x | 0.8x | 2.3x |
| Current ratio | 2.3x | 2.6x | 2.9x | 3.6x | 2.6x | 2.8x | 3.0x | 2.5x | 2.7x | 2.5x |
| Quick ratio | 1.1x | 1.3x | 2.0x | 2.5x | 1.5x | 1.8x | 1.9x | 1.3x | 2.0x | 1.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.9% | 5.1% | 3.3% | 4.1% | 5.3% | 5.3% | 5.2% | 8.3% | 8.1% | 7.5% |
| Stock comp / revenue | 0.9% | 1.0% | 1.0% | 0.9% | 1.1% | 1.1% | 1.1% | 1.5% | 1.1% | 1.8% |
| Payouts / FCF | 0.0% | 0.0% | 11.5% | 80.0% | 45.3% | 23.4% | 164.6% | 75.0% | 202.0% | 159.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 7.0 | 6.0 | 4.0 | 8.0 | 8.0 | 5.0 | 5.0 | 4.0 |
| Altman Z'' | 0.9 | 2.1 | 3.1 | 3.5 | 1.3 | 2.6 | 2.9 | 2.5 | 2.5 | 2.6 |
| Accruals ratio | β11.4% | β8.5% | β4.3% | 2.0% | β17.4% | β6.2% | β0.5% | β3.6% | β3.0% | 0.2% |
Source: SEC EDGAR XBRL filings (CIK 0000842633). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.